Alina Álvarez

443 total citations
18 papers, 298 citations indexed

About

Alina Álvarez is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Alina Álvarez has authored 18 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Alina Álvarez's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Herpesvirus Infections and Treatments (4 papers). Alina Álvarez is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Herpesvirus Infections and Treatments (4 papers). Alina Álvarez collaborates with scholars based in Cuba, Belgium and United States. Alina Álvarez's co-authors include Raúl J. Andrade, M. Isabel Lucena, Javier Salmerón, Luı́s Rodrigo, Muhammad Khawar Sana, Krunal Pandav, Vivian Kourí, Pedro Martı́nez, Jorge Pérez and Anne–Mieke Vandamme and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Alina Álvarez

18 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alina Álvarez Cuba 8 111 95 58 46 39 18 298
Λεωνιδία Λεωνίδου Greece 8 77 0.7× 112 1.2× 25 0.4× 28 0.6× 10 0.3× 23 337
Daniel Parks United States 12 54 0.5× 41 0.4× 32 0.6× 12 0.3× 9 0.2× 22 340
Gordana Dragović Serbia 11 152 1.4× 88 0.9× 33 0.6× 6 0.1× 30 0.8× 55 430
Adekunle Babajide Rowaiye Nigeria 8 75 0.7× 20 0.2× 23 0.4× 16 0.3× 20 0.5× 36 242
N. Ravichandran India 10 270 2.4× 167 1.8× 33 0.6× 16 0.3× 30 0.8× 15 353
Nardin Rezk United States 4 127 1.1× 23 0.2× 22 0.4× 49 1.1× 21 0.5× 4 212
Rustin D. Crutchley United States 12 233 2.1× 84 0.9× 35 0.6× 15 0.3× 28 0.7× 27 430
Yii Ean Teh Singapore 7 155 1.4× 86 0.9× 13 0.2× 152 3.3× 27 0.7× 10 417
Dandan Zhang China 10 479 4.3× 181 1.9× 46 0.8× 42 0.9× 31 0.8× 20 723
E. Schwartzman United States 5 56 0.5× 32 0.3× 23 0.4× 32 0.7× 12 0.3× 6 412

Countries citing papers authored by Alina Álvarez

Since Specialization
Citations

This map shows the geographic impact of Alina Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alina Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alina Álvarez more than expected).

Fields of papers citing papers by Alina Álvarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alina Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alina Álvarez. The network helps show where Alina Álvarez may publish in the future.

Co-authorship network of co-authors of Alina Álvarez

This figure shows the co-authorship network connecting the top 25 collaborators of Alina Álvarez. A scholar is included among the top collaborators of Alina Álvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alina Álvarez. Alina Álvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Loomba, Rohit, Kris V. Kowdley, José R Rodríguez-Medina, et al.. (2025). Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial. ˜The œLancet. Gastroenterology & hepatology. 10(8). 734–745. 7 indexed citations
2.
3.
Sana, Muhammad Khawar, et al.. (2021). Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19. World Journal of Virology. 10(2). 34–52. 16 indexed citations
4.
Pandav, Krunal, et al.. (2020). Omega 3 Fatty Acids and COVID-19: A Comprehensive Review. Infection and Chemotherapy. 52(4). 478–478. 100 indexed citations
5.
Kourí, Vivian, Alina Álvarez, Jorge Pérez, et al.. (2015). Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba. PLoS ONE. 10(2). e0117176–e0117176. 7 indexed citations
6.
Kourí, Vivian, Jorge Pérez, Yoeri Schrooten, et al.. (2013). Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba. Infection Genetics and Evolution. 16. 144–150. 23 indexed citations
7.
Martı́nez, Pedro, et al.. (2012). Normalización de un sistema de reacción en cadena de la polimerasa en tiempo real para la cuantificación de papilomavirus humano de alto riesgo oncogénico. SHILAP Revista de lepidopterología. 4 indexed citations
8.
Kourí, Vivian, Pedro Martı́nez, Virginia Capó, et al.. (2012). Kaposi’s Sarcoma and Human Herpesvirus 8 in Cuba: Evidence of subtype B expansion. Virology. 432(2). 361–369. 9 indexed citations
9.
Kourí, Vivian, Jorge Pérez, Yoeri Schrooten, et al.. (2012). High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba. Journal of Clinical Virology. 55(4). 348–355. 12 indexed citations
10.
Álvarez, Alina, et al.. (2012). Antiretroviral drug resistance in HIV‐1 therapy‐naïve patients in Cuba, 2006–2011. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
11.
Pérez, Jorge, et al.. (2012). Antiviral drug resistance in Cuban children infected with HIV‐1. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
12.
Pérez, Jorge, et al.. (2011). Drug-resistant HIV-1 in Cuban Children and their Seropositive Mothers. MEDICC Review. 13(2). 24–24. 4 indexed citations
13.
Martı́nez, Pedro, et al.. (2011). Role of herpesvirus as a cause of mononucleosis-like and febrile syndromes in Cuba, 2006-2009. MEDICC Review. 13(4). 45–49. 1 indexed citations
14.
Martı́nez, Pedro, Alina Álvarez, Ruperto González‐Pérez, et al.. (2010). HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008. Prenatal Diagnosis. 30(9). 888–892. 14 indexed citations
15.
Kourí, Vivian, et al.. (2010). Kaposi’s sarcoma-associated herpesvirus load in asymptomatic contacts of Cuban epidemic KS patients. Archives of Virology. 155(12). 1971–1976. 1 indexed citations
16.
Kourí, Vivian, Pedro Martı́nez, Alina Álvarez, et al.. (2010). Diagnosis and Screening for Cytomegalovirus Infection in Pregnant Women in Cuba as Prognostic Markers of Congenital Infection in Newborns. The Pediatric Infectious Disease Journal. 29(12). 1105–1110. 17 indexed citations
17.
Lucena, M. Isabel, et al.. (2000). Trovafloxacin-Induced Acute Hepatitis. Clinical Infectious Diseases. 30(2). 400–401. 75 indexed citations
18.
Gómez, Jorge A., et al.. (1991). [Seroepidemiology of human rotaviruses in a community of the Avellaneda district, Province of Buenos Aires].. PubMed. 22(4). 182–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Λεωνιδία Λεωνίδου Breakdown of academic impact, for papers by Daniel Parks Breakdown of academic impact, for papers by Gordana Dragović Breakdown of academic impact, for papers by Adekunle Babajide Rowaiye Breakdown of academic impact, for papers by N. Ravichandran Breakdown of academic impact, for papers by Nardin Rezk Breakdown of academic impact, for papers by Rustin D. Crutchley Breakdown of academic impact, for papers by Yii Ean Teh Breakdown of academic impact, for papers by Dandan Zhang Breakdown of academic impact, for papers by E. Schwartzman
Rankless by CCL
2026